Related references
Note: Only part of the references are listed.Introduction to the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Clifford R. Jack et al.
ALZHEIMERS & DEMENTIA (2011)
Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Reisa A. Sperling et al.
ALZHEIMERS & DEMENTIA (2011)
The Alzheimer’s Disease Neuroimaging Initiative: A review of papers published since its inception
Michael W. Weiner et al.
Alzheimers & Dementia (2011)
Identification of Candidate IgG Biomarkers for Alzheimer's Disease via Combinatorial Library Screening
M. Muralidhar Reddy et al.
CELL (2011)
PET imaging of brain amyloid in dementia: a review
Harriet Quigley et al.
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2011)
PLATELET AMYLOID PRECURSOR PROTEIN ISOFORM EXPRESSION IN ALZHEIMER'S DISEASE: EVIDENCE FOR PERIPHERAL MARKER
A. Vignini et al.
INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY (2011)
Identification of a blood-based biomarker panel for classification of Alzheimer's disease
Christoph Laske et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2011)
Plasma Clusterin and the Risk of Alzheimer Disease
Elisabeth M. C. Schrijvers et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Association of Plasma Clusterin Concentration With Severity, Pathology, and Progression in Alzheimer Disease
Madhav Thambisetty et al.
ARCHIVES OF GENERAL PSYCHIATRY (2010)
Platelet Alpha- and Beta-Secretase Activities are not Significantly Affected by Dementia or Mild Cognitive Impairment in Swedish Patients
P. Gorham et al.
CURRENT ALZHEIMER RESEARCH (2010)
Blood-based biomarkers of microvascular pathology in Alzheimer's disease
Michael Ewers et al.
EXPERIMENTAL GERONTOLOGY (2010)
Biological markers of amyloid β-related mechanisms in Alzheimer's disease
Harald Hampel et al.
EXPERIMENTAL NEUROLOGY (2010)
In vivo oxidative stress in brain of Alzheimer disease transgenic mice: Requirement for methionine 35 in amyloid beta-peptide of APP
D. Allan Butterfield et al.
FREE RADICAL BIOLOGY AND MEDICINE (2010)
High Plasma Levels of Vitamin E Forms and Reduced Alzheimer's Disease Risk in Advanced Age
Francesca Mangialasche et al.
JOURNAL OF ALZHEIMERS DISEASE (2010)
The Alzheimer's Disease Mitochondrial Cascade Hypothesis
Russell H. Swerdlow et al.
JOURNAL OF ALZHEIMERS DISEASE (2010)
Rethinking Alzheimer's Disease Therapy: Are Mitochondria the Key?
Maria Ankarcrona et al.
JOURNAL OF ALZHEIMERS DISEASE (2010)
Neuropathology of Alzheimer's Disease
Daniel P. Perl
MOUNT SINAI JOURNAL OF MEDICINE (2010)
Biomarkers for Alzheimer's disease: academic, industry and regulatory perspectives
Harald Hampel et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
ALZHEIMER DISEASE New light on an old CLU
Lars Bertram et al.
NATURE REVIEWS NEUROLOGY (2010)
Rate of progression of mild cognitive impairment to dementia - meta-analysis of 41 robust inception cohort studies
A. J. Mitchell et al.
ACTA PSYCHIATRICA SCANDINAVICA (2009)
Maximizing the Alzheimer's Disease Neuroimaging Initiative II
Maria C. Carrillo et al.
ALZHEIMERS & DEMENTIA (2009)
Identifying Early Markers of Alzheimer's Disease using Quantitative Multiplex Proteomic Immunoassay Panels
Holly D. Soares et al.
BIOMARKERS IN BRAIN DISEASE (2009)
Blood-Based Microcirculation Markers in Alzheimer's Disease-Diagnostic Value of Midregional Pro-atrial Natriuretic Peptide/C-terminal Endothelin-1 Precursor Fragment Ratio
Katharina Buerger et al.
BIOLOGICAL PSYCHIATRY (2009)
Fluorodeoxyglucose-Positron Emission Tomography in the differential diagnosis of early-onset dementia: a prospective, community-based study
Peter K. Panegyres et al.
BMC NEUROLOGY (2009)
Plasma biomarkers for mild cognitive impairment and Alzheimer's disease
Fei Song et al.
BRAIN RESEARCH REVIEWS (2009)
Amyloid beta, mitochondrial structural and functional dynamics in Alzheimer's disease
P. Hemachandra Reddy
EXPERIMENTAL NEUROLOGY (2009)
Use of Alzheimer Disease Biomarkers Potentially Yes for Clinical Trials but Not Yet for Clinical Practice
Ronald C. Petersen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
CSF Biomarkers and Incipient Alzheimer Disease in Patients With Mild Cognitive Impairment
Niklas Mattsson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Oxidatively modified, mitochondria-relevant brain proteins in subjects with Alzheimer disease and mild cognitive impairment
Rukhsana Sultana et al.
JOURNAL OF BIOENERGETICS AND BIOMEMBRANES (2009)
A leaky blood-brain barrier, fibrinogen infiltration and microglial reactivity in inflamed Alzheimer's disease brain
Jae K. Ryu et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2009)
The amyloid hypothesis for Alzheimer's disease: a critical reappraisal
John Hardy
JOURNAL OF NEUROCHEMISTRY (2009)
Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease
Denise Harold et al.
NATURE GENETICS (2009)
Core candidate neurochemical and imaging biomarkers of Alzheimer's disease
Harald Hampel et al.
ALZHEIMERS & DEMENTIA (2008)
IIC PiB and structural MRI provide complementary information in imaging of Alzheimers disease and amnestic mild cognitive impairment
Clifford R. Jack et al.
BRAIN (2008)
Proteome-based identification of plasma proteins associated with hippocampal metabolism in early Alzheimer's disease
Madhav Thambisetty et al.
JOURNAL OF NEUROLOGY (2008)
Markers of endothelial dysfunction in older subjects with late onset Alzheimer's disease or vascular dementia
G. Zuliani et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2008)
PET imaging of amyloid deposition in patients with mild cognitive impairment
Anton Forsberg et al.
NEUROBIOLOGY OF AGING (2008)
Platelet β-secretase activity is increased in Alzheimer's disease
J. A. Johnston et al.
NEUROBIOLOGY OF AGING (2008)
Peripheral Aβ subspecies as risk biomarkers of Alzheimer's disease
Nicole Schupf et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Hippocampal activation in adults with mild cognitive impairment predicts subsequent cognitive decline
S. L. Miller et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2008)
Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins
Sandip Ray et al.
NATURE MEDICINE (2007)
Research criteria for the diagnosis of Alzheimers disease: revising the NINCDS-ADRDA criteria
Bruno Dubois et al.
LANCET NEUROLOGY (2007)
Microvascular injury and blood-brain barrier leakage in Alzheimer's disease
B. D. Zipser et al.
NEUROBIOLOGY OF AGING (2007)
Association of low plasma Aβ42/Aβ40 ratios with increased imminent risk for mild cognitive impairment and Alzheimer disease
Neill R. Graff-Radford et al.
ARCHIVES OF NEUROLOGY (2007)
N-acetylaspartate in the CNS:: From neurodiagnostics to neurobiology
John R. Moffett et al.
PROGRESS IN NEUROBIOLOGY (2007)
Elevated platelet beta-secretase activity in mild cognitive impairment
W. W. Liu et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2007)
H-1 Magnetic resonance spectroscopy in dementia
K. Kantarci
BRITISH JOURNAL OF RADIOLOGY (2007)
Levels of beta-secretase (BACE1) in cerebrospinal fluid as a predictor of risk in mild cognitive impairment
Zhenyu Zhong et al.
ARCHIVES OF GENERAL PSYCHIATRY (2007)
CSF phosphorylated tau protein correlates with neocortical neurofibrillary pathology in Alzheimer's disease
Katharina Buerger et al.
BRAIN (2006)
Proteome-based plasma biomarkers for Alzheimer's disease
A. Hye et al.
BRAIN (2006)
Plasma Aβ1-40 and Aβ1-42 and the risk of dementia:: a prospective case-cohort study
Marieke van Oijen et al.
LANCET NEUROLOGY (2006)
Age and apolipoprotein E*4 allele effects on cerebrospinal fluid β-amyloid 42 in adults with normal cognition
Elaine R. Peskind et al.
ARCHIVES OF NEUROLOGY (2006)
Cerebrospinal fluid tau, Aβ, and phosphorylated tau protein for the diagnosis of Alzheimer's disease
Patrizia Formichi et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2006)
Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study
O Hansson et al.
LANCET NEUROLOGY (2006)
Circulating biomarkers of cognitive decline and dementia
V Solfrizzi et al.
CLINICA CHIMICA ACTA (2006)
Platelet amyloid precursor protein processing: A bio-marker for Alzheimer's disease
K Tang et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2006)
Pre-clinical diagnosis of Alzheimer disease combining platelet amyloid precursor protein ratio and rCBF spect analysis
B Borroni et al.
JOURNAL OF NEUROLOGY (2005)
Correlation of cerebrospinal fluid levels of Tau protein phosphorylated at threonine 231 with rates of hippocampal atrophy in Alzheimer disease
H Hampel et al.
ARCHIVES OF NEUROLOGY (2005)
Serum inflammatory proteins and cognitive decline in older persons
MG Dik et al.
NEUROLOGY (2005)
CSF Aβ42 and tau or phosphorylated tau and prediction of progressive mild cognitive impairment
SK Herukka et al.
NEUROLOGY (2005)
Cerebrospinal fluid TAU protein and amyloid β42 in mild cognitive impairment:: prediction of progression to Alzheimer's disease and correlation with the neuropsychological examination
A Ivanoiu et al.
NEUROCASE (2005)
Proteomic identification of proteins specifically oxidized by intracerebral injection of amyloid beta-peptide (1-42) into rat brain: Implications for Alzheimer's disease
D Boyd-Kimball et al.
NEUROSCIENCE (2005)
Inflammatory proteins in plasma and the risk of dementia - The Rotterdam study
MJ Engelhart et al.
ARCHIVES OF NEUROLOGY (2004)
Hippocampus and entorhinal cortex in mild cognitive impairment and early AD
C Pennanen et al.
NEUROBIOLOGY OF AGING (2004)
Core biological marker candidates of Alzheimer's disease -: perspectives for diagnosis, prediction of outcome and reflection of biological activity
H Hampel et al.
JOURNAL OF NEURAL TRANSMISSION (2004)
Platelet APP, ADAM 10 and BACE alterations in the early stages of Alzheimer disease
F Colciaghi et al.
NEUROLOGY (2004)
Mild cognitive impairment -: beyond controversies, towards a consensus:: report of the International Working Group on Mild Cognitive Impairment
B Winblad et al.
JOURNAL OF INTERNAL MEDICINE (2004)
Role of phenylalanine 20 in Alzheimer's amyloid,β-peptide (1-42)-induced oxidative stress and neurotoxicity
D Boyd-Kimball et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2004)
Medial temporal lobe function and structure in mild cognitive impairment
BC Dickerson et al.
ANNALS OF NEUROLOGY (2004)
Clearing amyloid through the blood-brain barrier
BV Zlokovic
JOURNAL OF NEUROCHEMISTRY (2004)
Platelet amyloid precursor protein abnormalities in mild cognitive impairment predict conversion to dementia Alzheimer type - A 2-year follow-up study
B Borroni et al.
ARCHIVES OF NEUROLOGY (2003)
Plasma Aβ40 and Aβ42 and Alzheimer's disease -: Relation to age, mortality, and risk
R Mayeux et al.
NEUROLOGY (2003)
Proteolytic processing of the Alzheimer's disease amyloid precursor protein in brain and platelets
G Evin et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2003)
CSF markers for incipient Alzheimer's disease
K Blennow et al.
LANCET NEUROLOGY (2003)
Inflammatory markers and cognition in well-functioning African-American and white elders
K Yaffe et al.
NEUROLOGY (2003)
Clinical biomarkers in drug discovery and development
R Frank et al.
NATURE REVIEWS DRUG DISCOVERY (2003)
Biological markers for therapeutic trials in Alzheimer's disease - Proceedings of the biological markers working group; NIA initiative on neuroimaging in Alzheimer's disease
RA Frank et al.
NEUROBIOLOGY OF AGING (2003)
CSF Aβ 42 levels correlate with amyloid-neuropathology in a population-based autopsy study
D Strozyk et al.
NEUROLOGY (2003)
CSF tau protein phosphorylated at threonine 231 correlates with cognitive decline in MCI subjects
K Buerger et al.
NEUROLOGY (2002)
Differential diagnosis of Alzheimer disease with cerebrospinal fluid levels of tau protein phosphorylated at threonine 231
K Buerger et al.
ARCHIVES OF NEUROLOGY (2002)
Early inflammation and dementia: A 25-year follow-up of the Honolulu-Asia aging study
R Schmidt et al.
ANNALS OF NEUROLOGY (2002)
Abnormalities in the pattern of platelet amyloid precursor protein forms in patients with mild cognitive impairment and Alzheimer disease
A Padovani et al.
ARCHIVES OF NEUROLOGY (2002)
Decreased CSF-beta-amyloid 42 in Alzheimer's disease and amyotrophic lateral sclerosis may reflect mismetabolism of beta-amyloid induced by disparate mechanisms
M Sjogren et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2002)
Magnetic resonance imaging of the entorhinal cortex and hippocampus in mild cognitive impairment and Alzheimer's disease
AT Du et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2001)
The molecular bases of Alzheimer's disease and other neurodegenerative disorders
RB Maccioni et al.
ARCHIVES OF MEDICAL RESEARCH (2001)
Highly increased CSF tau protein and decreased β-amyloid (1-42) in sporadic CJD:: a discrimination from Alzheimer's disease?
E Kapaki et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2001)
Amyloid β protein 1-40 and 1-42 levels in matched cerebrospinal fluid and plasma from patients with Alzheimer disease
PD Mehta et al.
NEUROSCIENCE LETTERS (2001)
Human neurons generate C-reactive protein and amyloid P: upregulation in Alzheimer's disease
K Yasojima et al.
BRAIN RESEARCH (2000)
Standardization of measurement of β-amyloid(1-42) in cerebrospinal fluid and plasma
H Vanderstichele et al.
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS (2000)
Rates of hippocampal atrophy correlate with change in clinical status in aging and AD
CR Jack et al.
NEUROLOGY (2000)
Platelet APP isoform ratios correlate with declining cognition in AD
F Baskin et al.
NEUROLOGY (2000)
Decreased CSF amyloid β42 and normal tau levels in dementia with Lewy bodies
K Kanemaru et al.
NEUROLOGY (2000)
Hippocampus in Alzheimer's disease: A 3-year follow-up MRI study
MP Laakso et al.
BIOLOGICAL PSYCHIATRY (2000)
Inflammation and Alzheimer's disease
H Akiyama et al.
NEUROBIOLOGY OF AGING (2000)
Alzheimer's disease and its focal variants
JH Kramer et al.
SEMINARS IN NEUROLOGY (2000)
Plasma and cerebrospinal fluid levels of amyloid beta proteins 1-40 and 1-42 in Alzheimer disease
PD Mehta et al.
ARCHIVES OF NEUROLOGY (2000)
Share Paper
